Breast Fibroadenoma With Increased Activity on 68Ga DOTATATE PET/CT.
- Papadakis GZ From the *Department of Radiology and Imaging Sciences, Warren Grant Magnuson Clinical Center, †PET Department, Clinical Center, and ‡Endocrine Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD; §Endocrine and Thoracic Surgery, University Hospitals of Geneva, Geneva, Switzerland; ∥Department of Radiology, Medical School, University of Crete, Greece; and ¶Center for Research in Computer Vision, Electrical and Computer Science Department, University of Central Florida, Orlando, FL.
- Millo C
- Sadowski SM
- Karantanas AH
- Bagci U
- Patronas NJ
- 2016-11-24
Published in:
- Clinical nuclear medicine. - 2017
Adult
Breast Neoplasms
Female
Fibroadenoma
Humans
Neuroendocrine Tumors
Organometallic Compounds
Positron Emission Tomography Computed Tomography
Radiopharmaceuticals
English
Fibroadenoma is the most common benign breast tumor in women of reproductive age, carrying little to no risk of breast cancer development. We report on a case of a woman with history of neuroendocrine tumor who on follow-up imaging tests underwent whole-body PET/CT study using Ga DOTATATE. The scan showed increased focal activity in the right breast, which was biopsied revealing a fibroadenoma. The presented data suggests cell surface overexpression of somatostatin receptors by this benign breast tumor. Moreover, this finding emphasizes the need for cautious interpretation of Ga DOTATATE-avid breast lesions that could mimic malignancy in neuroendocrine tumor patients.
- Language
-
- English
- Open access status
- green
- Identifiers
-
- DOI 10.1097/RLU.0000000000001463
- PMID 27879489
- Persistent URL
- https://sonar.ch/global/documents/232637
Statistics
Document views: 27
File downloads:
- Full-text: 0